BURON NUTRASCIENCE CORP - BRCNF STOCK NEWS

Burcon NutraScience announced the appointment of Robert Peets as the new Chief Financial Officer (CFO), effective July 1, 2024. Peets, with over 30 years of experience in financial management and capital markets, will succeed Jade Cheng, who is stepping down for personal reasons on June 30, 2024. Peets presently serves as a fractional CFO for multiple technology companies and previously held a prominent role at TELUS Ventures. Burcon's CEO, Kip Underwood, expressed gratitude to Cheng for her significant contributions over the past 25 years and welcomed Peets, emphasizing his expertise in capital market strategies.

Burcon NutraScience reported its fiscal 2024 results, highlighting significant milestones including scaled commercial production of the world's first 95% hempseed protein isolate and a $40 billion addressable market for its high-purity protein ingredients. The company recorded a net loss of $7.5 million, a significant reduction from the previous year's $25.4 million loss, attributed to the write-off related to Merit Functional Foods Operational expenses decreased by $686,000, with notable reductions in R&D and G&A expenses. Additionally, Burcon raised $7.8 million through private placements and secured a $5 million loan tranche. The company is set to increase production and sales to meet growing customer demand.

Burcon NutraScience (TSX: BU, OTCQB: BRCNF) has successfully completed its first contract research project, opening a new revenue stream. The company, known for its plant-based proteins, aims to leverage its expertise in future projects, with several discussions already underway. Burcon's Winnipeg Technical Centre, equipped with advanced commercial processing tools, enables comprehensive food process development, validation, and scale-up. CEO Kip Underwood and SVP Randy Willardsen highlight the strategic alignment and complementary nature of these services with Burcon's core business.

Burcon NutraScience (TSX: BU, OTCQB: BRCNF) will host a conference call and webcast on June 26, 2024, at 5:00 p.m. Eastern to discuss its financial results for the fiscal year ending March 31, 2024. The financial results will be issued via press release beforehand. Investors can access the webcast on Burcon's website under 'Presentations.' The webcast will be archived for future playback. Dial-in details for the live call are provided, including toll-free and international numbers, and a conference ID.

Burcon NutraScience has announced the launch of its high-purity, nutritionally complete canola protein. Derived from non-GMO, Canadian-grown canola seeds, this protein isolate contains all nine essential amino acids with a PDCAAS of 1 and over 90% protein purity. It offers a neutral flavor, high solubility, superior foaming, and exceptional functionality, making it suitable for various food and beverage products.

Burcon plans to begin commercial production and sales in the latter half of this year. The product has received positive feedback from prospective customers. Burcon has also converted its exclusive license with Merit Functional Foods to a non-exclusive one, allowing it to market and sell its canola protein more broadly.

Burcon NutraScience has announced that its common shares have begun trading on the OTCQB Venture Market under the symbol BRCNF, effective May 8, 2024. This move aims to enhance accessibility for US investors and support the company’s focus areas for 2024, which include increasing production to meet hempseed protein demand and introducing new plant-based proteins via a capital-light business model. CEO Kip Underwood emphasized that this development provides more investors with the opportunity to participate in Burcon's growth and its path towards profitability through innovation in plant proteins.

Burcon NutraScience and HPS Food and Ingredients Inc. have achieved the first commercial sales of the world's first hemp protein isolate. This milestone marks a significant partnership in the rapidly growing market for plant-based proteins. Burcon's capital-light approach has allowed them to establish a route-to-market for their high purity hemp protein, enabling speed and influence over production. The company is ramping up production to meet increasing demand, with consumer product launches expected later in 2024.

HPS Food & Ingredients invites attendees to visit booth #721 for more information

Burcon NutraScience (TSX: BU) announces the successful completion of end-to-end validation trials and the start of commercial-scale production for the world's first high purity 95% hempseed protein isolate. The company has achieved a significant milestone with the successful scale-up of its groundbreaking hempseed protein isolate, aiming to meet growing customer demand and capture value for shareholders.